What is SigTuple?
Founded in 2015, SigTuple is an innovative healthtech enterprise headquartered in Bengaluru, India. The company specializes in building intelligent screening solutions that utilize artificial intelligence to automate the analysis of visual medical data. By integrating sophisticated algorithms into clinical workflows, SigTuple empowers healthcare providers to perform faster, more reliable diagnostics. Its market position is defined by its ability to bridge the gap between high-volume diagnostic needs and the scarcity of specialized medical professionals, positioning it as a vital infrastructure provider in the digital health ecosystem.
How much funding has SigTuple raised?
SigTuple has raised a total of $52.1M across 4 funding rounds:
Series A
$5.8M
Series B
$19M
Series C
$23.3M
Series C
$4M
Series A (2017): $5.8M with participation from Endiya Partners, Accel Partners, IDG Capital, Pi Ventures, and Axilor Ventures
Series B (2018): $19M led by Trifecta Capital Services, Axilor Ventures, Binny Bansal, Venture Highway, pi Ventures, Ridge Ventures, Endiya Partners, and Accel
Series C (2023): $23.3M supported by Chiratae Ventures, Pi Ventures, Trifecta Capital Services, Accel Partners, Binny Bansal, Trusted Insights, and Endiya Partners
Series C (2024): $4M featuring SIDBI Venture Capital and Endiya Partners
Key Investors in SigTuple
SIDBI Venture Capital
SIDBI Venture Capital Limited is an investment management firm focused on providing venture capital to startups and MSMEs across various sectors in India, aiming to foster innovation and drive growth.
Endiya Partners
Endiya Partners is an early-stage venture capital fund that focuses on investing in Indian product startups within the sectors of enterprise, industrial technology, healthcare, and life sciences.
Chiratae Ventures
Chiratae Ventures is an established Indian technology venture capital fund advisor based in Bengaluru, managing significant assets with a strong track record of supporting early-stage and portfolio companies.
What's next for SigTuple?
With the recent infusion of capital, SigTuple is well-positioned to accelerate its product roadmap and expand its footprint in international markets. The strategic focus will likely center on enhancing its AI diagnostic accuracy, scaling its cloud-based platform, and forging deeper partnerships with global healthcare institutions. As the company moves beyond its Series C stage, the emphasis will shift toward operational excellence and long-term sustainability, ensuring that its AI-powered diagnostic tools become a standard component of modern clinical practice. The continued support from its investor base provides the necessary resources to navigate the complexities of global health regulations and competitive market dynamics.
See full SigTuple company page
